We are live on ! Find out more
BAM

Bellevue Asset Management Portfolio holdings

AUM $217M
1-Year Est. Return 14.36%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+14.36%
3 Year Est. Return
+56.75%
5 Year Est. Return
+72.55%
10 Year Est. Return
AUM
$164M
AUM Growth
+$2.6M
Cap. Flow
-$8.74M
Cap. Flow %
-5.33%
Top 10 Hldgs %
57.47%
Holding
663
New
24
Increased
86
Reduced
202
Closed
81

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.63M
2
INTC icon
Intel
INTC
+$883K
3
SBUX icon
Starbucks
SBUX
+$555K
4
CSCO icon
Cisco
CSCO
+$441K
5
IYF icon
iShares US Financials ETF
IYF
+$437K

Sector Composition

Rank Sector Weight
1 Technology 36.09%
2 Consumer Discretionary 10.54%
3 Healthcare 5.26%
4 Consumer Staples 3.33%
5 Financials 2.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYX
551
DELISTED
Alteryx Inc
AYX
$2K ﹤0.01%
21
-2
-9% -$164
TWNK
552
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$2K ﹤0.01%
125
-14
-10% -$218
SGFY
553
DELISTED
Signify Health, Inc.
SGFY
$2K ﹤0.01%
66
-6
-8% -$165
UMPQ
554
DELISTED
Umpqua Holdings Corp
UMPQ
$2K ﹤0.01%
100
ZEN
555
DELISTED
ZENDESK INC
ZEN
$2K ﹤0.01%
15
-2
-12% -$282
TWTR
556
DELISTED
Twitter, Inc.
TWTR
$2K ﹤0.01%
+30
New +$1.84K
GBT
557
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2K ﹤0.01%
52
-5
-9% -$195
RDS.B
558
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$2K ﹤0.01%
50
-50
-50% -$1.88K
APA icon
559
APA Corp
APA
$12.9B
$1K ﹤0.01%
+50
New +$1.03K
AYTU icon
560
AYTU BioPharma
AYTU
$25M
$1K ﹤0.01%
13
BPMC
561
DELISTED
Blueprint Medicines
BPMC
$1K ﹤0.01%
15
-2
-12% -$183
CAH icon
562
Cardinal Health
CAH
$55.7B
$1K ﹤0.01%
22
-249
-92% -$14.5K
CMPS
563
Compass Pathways
CMPS
$1.83B
$1K ﹤0.01%
+30
New +$1.07K
DG icon
564
Dollar General
DG
$28.1B
$1K ﹤0.01%
+6
New +$1.26K
DOX icon
565
Amdocs
DOX
$6.28B
$1K ﹤0.01%
15
-58
-79% -$4.48K
FNDF icon
566
Schwab Fundamental International Large Company Index ETF
FNDF
$25.2B
$1K ﹤0.01%
44
FNF icon
567
Fidelity National Financial
FNF
$14.1B
$1K ﹤0.01%
28
-9
-24% -$393
FWONK icon
568
Liberty Media Series C
FWONK
$25B
$1K ﹤0.01%
26
+2
+8% +$88
HAE icon
569
Haemonetics
HAE
$3.86B
$1K ﹤0.01%
21
-2
-9% -$142
HHH icon
570
Howard Hughes
HHH
$4.06B
$1K ﹤0.01%
12
PPLI
571
People Inc
PPLI
$3.2B
$1K ﹤0.01%
9
-4
-31% -$518
KURA icon
572
Kura Oncology
KURA
$824M
$1K ﹤0.01%
56
-7
-11% -$174
MCO icon
573
Moody's
MCO
$81.9B
$1K ﹤0.01%
4
MLM icon
574
Martin Marietta Materials
MLM
$32.3B
$1K ﹤0.01%
4
PGR icon
575
Progressive
PGR
$125B
$1K ﹤0.01%
+11
New +$1.09K

Similar funds

Bellevue Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Bellevue Asset Management held 663 positions worth $164M, up 1.6% from $161M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Bellevue Asset Management withdrew a net $8.74M in Q2 2021, closing 81 positions and reducing 202 holdings. Its most notable exit was Timberland Bancorp, an estimated $356K position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bellevue Asset Management opened a new position in PIMCO Enhanced Low Duration Active Exchange-Traded Fund worth $75K.

  • Bellevue Asset Management's largest Q2 2021 buy was PIMCO Enhanced Low Duration Active Exchange-Traded Fund: 736 shares worth $75K.
  • Bellevue Asset Management added most to First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF in Q2 2021, an estimated $587K increase.
  • Bellevue Asset Management's biggest Q2 2021 reduction was Microsoft, cutting an estimated $3.63M.
  • Bellevue Asset Management fully exited Timberland Bancorp in Q2 2021, selling an estimated $356K.
  • Bellevue Asset Management's ten largest holdings make up 57% of its $164M portfolio in Q2 2021.
  • Bellevue Asset Management opened 24 new positions and closed 81 in Q2 2021.
  • Bellevue Asset Management's portfolio value rose 1.6% quarter-over-quarter to $164M.

Based on Bellevue Asset Management's 13F filing for Q2 2021, filed 9 Aug 2021.